Carcinoma: all 6,715 studies

Page 36 of 68. Open to participants first (1,140), then studies with results posted, then the rest; newest registration first within each.

• Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsTerminatedNCT04301011Phase 1
• Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell CarcinomaTerminatedNCT04300140Phase 1/2
• The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive TreatmentStatus unknownNCT04299919
• Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community PracticeCompletedNCT04297384Not applicable
• TACE Combined with Anti-PD-1 Antibody in Patients with Advanced Hepatocellular CarcinomaCompletedNCT04297280Phase 2
• A Study to Assess the Safety and Efficacy of Lenvatinib as First-line Treatment in Participants With Unresectable HCCCompletedNCT04297254Phase 4
• SHR-1210 Combined With Apatinib Mesylate in the Perioperative Treatment of Hepatocellular CarcinomaStatus unknownNCT04297202Phase 2
• Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal CancerStatus unknownNCT04296747Phase 2
• The Mechanism of Sox4 Transcription in Regulation of Angiogenesis in Hepatocellular CarcinomaCompletedNCT04296058
• Vasculogenic Mimicry in Urothelial CarcinomaStatus unknownNCT04295967
• TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon CancerActive, not recruitingNCT04294264Phase 2
• Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCCCompletedNCT04293679Phase 1/2
• Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer PatientsCompletedNCT04291300Phase 2
• SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT04282070Phase 1
• Mechanical Bowel Preparation and Oral Antibiotics Versus Mechanical Bowel Preparation Only Prior Rectal SurgeryActive, not recruitingNCT04281667Phase 4
• Effect of Androgen Receptor Signaling Inhibitors on 68Ga-PSMA-11 PET/CT Imaging in Patients With Castration-Resistant Prostate CancerTerminatedNCT04279561Phase 1
• Topical Vitamin C for Treatment of Basal Cell CancerCompletedNCT04279535Early Phase 1
• Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.WithdrawnNCT04276597Phase 2
• Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal CarcinomaStatus unknownNCT04275986Phase 2
• PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of HCCStatus unknownNCT04273100Phase 2
• Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial)WithdrawnNCT04267913Phase 2
• Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL StudyCompletedNCT04267874Early Phase 1
• Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in DiameterCompletedNCT04264962Early Phase 1
• Characterization of Methylation Patterns in Hepatocellular CarcinomaTerminatedNCT04264754
• Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer PatientsStatus unknownNCT04262518Not applicable
• The CAPER Trial: A Phase Ib Clinical Trial of Cyclophosphamide And PEmbrolizumab in Metastatic Renal Cell CarcinomaStatus unknownNCT04262427Phase 1/2
• A Multi-Cancer, Multi-State, Platform Study of Durvalumab (MEDI4736) and Oleclumab (MEDI9447) in Pancreatic Adenocarcinoma, Non-Small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck to Correlate Clinical, Molecular and Immunologic Parameters With DNA MethylationWithdrawnNCT04262388Phase 2
• Targeted Therapy and Avelumab in Merkel Cell CarcinomaActive, not recruitingNCT04261855Phase 1/2
• Trial of NanoDoce Intratumoral Injection in Renal Cell CarcinomaWithdrawnNCT04260360Phase 1
• Epigenetic Changes in Head and Neck CancerCompletedNCT04260074
• Feasibility of a Carbohydrate-restricted, High-fat Diet on Head and Neck Squamous Cell Carcinoma OutcomesCompletedNCT04253808Not applicable
• Biological Outcomes of Pramlintide in Resectable Cutaneous Squamous Cell Carcinoma: A Pilot StudyWithdrawnNCT04252612Early Phase 1
• The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.CompletedNCT04252560
• P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)TerminatedNCT04249947Phase 1
• Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerWithdrawnNCT04249167Early Phase 1
• Surgical Treatment of Pancreatic Metastases From Renal Cell CarcinomaStatus unknownNCT04245410
• A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesTerminatedNCT04244552Phase 1
• Efficacy and Safety of Lenvatinib as a Conversion Therapy for HCCStatus unknownNCT04241523Phase 2
• A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular CarcinomaStatus unknownNCT04239781
• Relenvatinib in the Tatment of Recurrence of Hepatocellular Carcinoma After Liver TransplantationStatus unknownNCT04237740Phase 3
• P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular CarcinomaStatus unknownNCT04233840Phase 1/2
• Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal CarcinomatosisTerminatedNCT04232384Not applicable
• Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal CancerWithdrawnNCT04231864Phase 2
• Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal CancerStatus unknownNCT04231175Not applicable
• Anrotenib Plus Toripalimab Versus Toripalimab in Patients With Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04229849Phase 2
• Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRCStatus unknownNCT04229537Phase 1
• DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular CarcinomaStatus unknownNCT04229355Phase 3
• Efficacy and Safety of Lenvatinib as an Adjuvant Therapy for Hepatocellular CarcinomaStatus unknownNCT04227808Phase 2
• Efficacy of Neoadjuvant PD-1 Blockade Plus Chemotherapy for Esophageal Squamous Cell CarcinomaCompletedNCT04225364Phase 2
• Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal CarcinomaActive, not recruitingNCT04223024Phase 2
• Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT ImagingStatus unknownNCT04222543Phase 2
• Uro-DNA Collection for Expanded Genome-Wide Association Study (GWAS) of Renal Cell Carcinoma (RCC)CompletedNCT04222374
• Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCCStatus unknownNCT04221347
• A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal CarcinomaCompletedNCT04220307Phase 2
• Epigenetic Changes in Hepatocellular Carcinoma Developed After Direct Acting Antiviral Therapy for Chronic Hepatitis CStatus unknownNCT04220151
• NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNomaStatus unknownNCT04215471Phase 2
• PSMA-PET Imaging Before and After ADT in Advanced SDC PatientsStatus unknownNCT04214353Not applicable
• Heated Intra-peritoneal Chemotherapy with Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsTerminatedNCT04213794Early Phase 1
• Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.Status unknownNCT04213664
• Ribociclib and Spartalizumab in R/M HNSCCStatus unknownNCT04213404Phase 1
• Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery RecurrenceStatus unknownNCT04213118Phase 2
• A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial CarcinomaStatus unknownNCT04211012Phase 2
• Interest of the Intervention of a Nurse Coordinator in Complex Care PathwayStatus unknownNCT04209491
• Support Program for Adoption of Cancer Screening Interventions at a Rural Community-Based OrganizationCompletedNCT04208724Not applicable
• Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell CarcinomaTerminatedNCT04203901Phase 2
• Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular CarcinomaStatus unknownNCT04202523Phase 3
• High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral NeuropathyActive, not recruitingNCT04201561Phase 3
• Surgery Plus Intraoperative Radiotherapy as Treatment for Squamous Cell Carcinoma Over Pilonidal Disease.CompletedNCT04201002
• A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial CarcinomaCompletedNCT04200963Phase 1
• To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing ChemoradiotherapyCompletedNCT04199832
• Biological Effect of Vitamin D in Patients With Urothelial CarcinomaCompletedNCT04197089Phase 4
• 18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCCStatus unknownNCT04196985Not applicable
• A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT04196283Phase 1
• RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC)Status unknownNCT04193696Phase 2
• Sleep Apnoea Syndrome and Hepatocellular CarcinomaWithdrawnNCT04190498
• Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and RecommendationsStatus unknownNCT04189809
• Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSASCompletedNCT04189107Phase 3
• Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based ChemotherapyCompletedNCT04188860Phase 2
• LITT and Pembrolizumab in Recurrent Brain MetastasisTerminatedNCT04187872Phase 1
• A Study of CS1001 in Subjects With Esophageal Squamous Cell CarcinomaCompletedNCT04187352Phase 3
• [18F]-AraG for the Detection of T-Cell Activation in Advanced Non-small Cell Lung Cancer Patients Undergoing PD-1/PD-L1-Directed TherapyWithdrawnNCT04186988Early Phase 1
• Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deletedTerminatedNCT04185311Phase 1
• Regorafenib Plus Tislelizumab as First-line Systemic Therapy for Patients With Advanced Hepatocellular CarcinomaStatus unknownNCT04183088Phase 2
• Neo-TACE-HAIC for PVTT-HCCStatus unknownNCT04181931Not applicable
• A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other CancersCompletedNCT04180215Phase 1/2
• Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint InhibitorWithdrawnNCT04179110Phase 2
• The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-LipiodolWithdrawnNCT04178642Phase 2
• A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior TreatmentTerminatedNCT04178460Phase 1
• Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04177797Phase 2
• Hypermethylation of VTRNA2-1 Promoter in HCC OutcomeCompletedNCT04177316
• Anti-PD-1 Antibody Plus DEB-TACE for BCLC Stage A/B HCCStatus unknownNCT04174781Phase 2
• A Study of the Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)CompletedNCT04172571Phase 2
• Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular CarcinomasCompletedNCT04172194
• Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING)CompletedNCT04170556Phase 1/2
• Performance of White Light, NBI and Iodine Staining Endoscopy in the Diagnosis of Esophageal LesionsStatus unknownNCT04170257Not applicable
• Systemic Chemotherapy Plus Lenvatinib and Toripalimab for HCC With Extrahepatic MetastasisStatus unknownNCT04170179Phase 2
• Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTTStatus unknownNCT04169399Phase 2
• Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular CarcinomaStatus unknownNCT04168944Phase 2/3
• Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)Status unknownNCT04167293Phase 2/3
• Neoadjuvant Anti-PD-1 Antibody (Toripalimab) or Combined With Chemotherapy in HNSCC PatientsStatus unknownNCT04164238Phase 2

← Carcinoma overview